Skip to content
10-Q

Quarterly Report

FATE THERAPEUTICS, INC. FATE

0000950170-25-107309

← back to feed
Filed
Aug 12, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q2 2025 · Aug 5, 2025 115.33M sh
Shares Diluted Q2 2025 · Jun 30, 2025 118.53M sh
Shares Diluted Q2 2025 · Jun 30, 2025 118.45M sh
Shares Diluted Q2 2025 · Jun 30, 2024 117.47M sh
Shares Diluted Q2 2025 · Jun 30, 2024 109.29M sh
Capex Q2 2025 · Jun 30, 2025 $2.56M
Capex Q2 2025 · Jun 30, 2024 $137K
Operating Cash Flow Q2 2025 · Jun 30, 2025 −$58.4M
Operating Cash Flow Q2 2025 · Jun 30, 2024 −$65.66M
Short Term Investments Q2 2025 · Jun 30, 2025 $181.58M
Short Term Investments Q2 2025 · Dec 31, 2024 $243.01M
Cash And Equivalents Q2 2025 · Jun 30, 2025 $41.25M
Cash And Equivalents Q2 2025 · Dec 31, 2024 $36.06M
Cash And Equivalents Q2 2025 · Jun 30, 2024 $36.92M
Stockholders Equity Q2 2025 · Jun 30, 2025 $261.36M
Stockholders Equity Q2 2025 · Mar 31, 2025 $288.41M
Stockholders Equity Q2 2025 · Dec 31, 2024 $318.73M
Stockholders Equity Q2 2025 · Jun 30, 2024 $396.98M
Stockholders Equity Q2 2025 · Mar 31, 2024 $426.12M
Stockholders Equity Q2 2025 · Dec 31, 2023 $368.42M
Current Liabilities Q2 2025 · Jun 30, 2025 $28.67M
Current Liabilities Q2 2025 · Dec 31, 2024 $38.52M
Current Assets Q2 2025 · Jun 30, 2025 $230.4M
Current Assets Q2 2025 · Dec 31, 2024 $291.91M
Total Assets Q2 2025 · Jun 30, 2025 $371.63M
Total Assets Q2 2025 · Dec 31, 2024 $440.69M
Eps Diluted Q2 2025 · Jun 30, 2025 −$0.29
Eps Diluted Q2 2025 · Jun 30, 2025 −$0.61
Eps Diluted Q2 2025 · Jun 30, 2024 −$0.33
Eps Diluted Q2 2025 · Jun 30, 2024 −$0.79
Eps Basic Q2 2025 · Jun 30, 2025 −$0.29
Eps Basic Q2 2025 · Jun 30, 2025 −$0.61
Eps Basic Q2 2025 · Jun 30, 2024 −$0.33
Eps Basic Q2 2025 · Jun 30, 2024 −$0.79
Sga Expense Q2 2025 · Jun 30, 2025 $11.45M
Sga Expense Q2 2025 · Jun 30, 2025 $25.22M
Sga Expense Q2 2025 · Jun 30, 2024 $17.25M
Sga Expense Q2 2025 · Jun 30, 2024 $38.11M
Rd Expense Q2 2025 · Jun 30, 2025 $27.43M
Rd Expense Q2 2025 · Jun 30, 2025 $56.57M
Rd Expense Q2 2025 · Jun 30, 2024 $34.6M
Rd Expense Q2 2025 · Jun 30, 2024 $66.74M
Net Income Q2 2025 · Jun 30, 2025 −$34.07M
Net Income Q2 2025 · Jun 30, 2025 −$71.69M
Net Income Q2 2025 · Mar 31, 2025 −$37.62M
Net Income Q2 2025 · Jun 30, 2024 −$38.43M
Net Income Q2 2025 · Jun 30, 2024 −$86.43M
Net Income Q2 2025 · Mar 31, 2024 −$48M
Operating Income Q2 2025 · Jun 30, 2025 −$36.97M
Operating Income Q2 2025 · Jun 30, 2025 −$78.25M
Operating Income Q2 2025 · Jun 30, 2024 −$45.08M
Operating Income Q2 2025 · Jun 30, 2024 −$96.15M
Revenue Q2 2025 · Jun 30, 2025 $1.91M
Revenue Q2 2025 · Jun 30, 2025 $3.54M
Revenue Q2 2025 · Jun 30, 2024 $6.77M
Revenue Q2 2025 · Jun 30, 2024 $8.7M